[What Is the Optimal Drug Regimen for Helicobacter pylori Eradication Therapy?]
- PMID: 40502845
- PMCID: PMC11974585
- DOI: 10.7704/kjhugr.2024.0022
[What Is the Optimal Drug Regimen for Helicobacter pylori Eradication Therapy?]
Conflict of interest statement
Conflicts of Interest The authors have no financial conflicts of interest.
References
-
- Lee JH, Ahn JY, Choi KD, et al. Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: a prospective multicenter study. Helicobacter. 2019;24:e12592. - PubMed
-
- Kwon YH. The current strategy of Helicobacter pylori eradication. Korean J Med. 2021;96:13–21.
-
- Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;71:1724–1762.
Publication types
LinkOut - more resources
Full Text Sources